- Professor Myron Levine, Professor & Director, Center for Vaccine Development, University of Maryland School of Medicine
- Dr Seth Berkley, President & CEO, IAVI
- Dr Kanwarjit Singh, Senior Program Officer, Policy & Finance, Bill & Melinda Gates Foundation
- Dr William Gruber, Vice President, Clinical Research, Wyeth Vaccines
- Una S. Ryan, OBE, PhD, President & CEO, Diagnostics For All
- Dr Rino Rappuoli, Global Head, Vaccines Research, Novartis Vaccines & Diagnostics
- Dr Allan P. Jarvis, Vice President, Corporate Development, sanofi pasteur
- Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems & Venture Partner, Burrill & Company
- Dr Ronald W. Ellis, Senior Vice President, Research & Development, NasVax Ltd
- Heather L. Davis, PhD, Executive Director, Pfizer Global R&D, Vaccines Research; Site Head, Ottawa Laboratories
- Dr Steve Chatfield, Senior Vice President, Strategic Investments, Emergent Biosolutions
|
- Dr Vincent Brichard, Vice President, Cancer Immunotherapeutics, GlaxoSmithKline Biologicals
- Dr Martin Bachmann, CSO, Cytos Biotechnology AG
- Dr Axel Hoos, Co-Chair, Executive Committee, Cancer Immunotherapy Consortium (CIC) & Medical Lead, Ipilimumab Program, Bristol-Myers Squibb
- Dr Jean-Yves Bonnefoy, Vice President, R&D, Transgene
- Professor Angus Dalgleish, Professor of Oncology, St George's, University of London
- Dr David Urdal, Chief Scientific Officer, Dendreon Corporation
- Dr Hans A. Küpper, Partner, Global Life Science Ventures
Please visit this page over the coming weeks to view new additions to the Active Immunotherapeutics Forum 2011 Advisory Board
|
